Kyowa Kirin To Offload Selected Mature Portfolio To Grünenthal

New JV Set For '26 Buy-Out

 
• By Lisa Takagi

The Japanese and German firms agree to establish a joint company to handle 13 mature brands from Kyowa Kirin's portfolio, mainly focused on pain management and including Abstral and PecFent. Grünenthal will own 51% and plans to fully buy out the operation in early 2026.

Kyowa Kirin and Grünenthal
Grünenthal and Kyowa Kirin enter JV for Japanese firm's established medicines • Source: Shutterstock

More from Business

More from Scrip